4.6 Article

Inhibition of cancer cell growth by ruthenium(II) cyclopentadienyl derivative complexes with heteroaromatic ligands

Journal

JOURNAL OF INORGANIC BIOCHEMISTRY
Volume 103, Issue 3, Pages 354-361

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jinorgbio.2008.11.016

Keywords

Atomic force microscopy (AFM); Ruthenium(II); Cyclopentadienyl derivatives; X-ray structures; Antiproliferative assays

Funding

  1. Fundacao para a Ciencia e Tecnologia [POCTI/QUI/48433/2002]
  2. Ministerio Educacion y Ciencia [BQU2005-01834]
  3. FCT [SFRH/BD/12432/2003]
  4. Fundação para a Ciência e a Tecnologia [SFRH/BD/12432/2003] Funding Source: FCT

Ask authors/readers for more resources

Inhibition of the growth of LoVo human colon adenocarcinoma and MiaPaCa pancreatic cancer cell lines by two new organometallic ruthenium(II) complexes of general formula [Ru(eta(5)-C5H5)(PP) L][CF3SO3], where PP is 1,2-bis(diphenylphosphino)ethane and L is 1,3,5-triazine (Tzn) 1 or PP is 2x triphenylphosphine and L is pyridazine (Pyd) 2 has been investigated. Crystal structures of compounds I and 2 were determined by X-ray diffraction studies. Atomic force microscopy (AFM) images suggest different mechanisms of interaction with the plasmid pBR322 DNA; while the mode of binding of compound 1 could be intercalation between base pairs of DNA, compound 2 might be involved in a covalent bond formation with N from the purine base. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available